Composiciones, usos y métodos para el tratamiento de trastornos y enfermedades metabólicos
Un péptido quimérico que comprende o consiste en SEQ ID NO:2, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:69, o SEQ ID NO:70. The invention relates to a fusion of fibroblast growth factor 19 (FGF19) and fibroblast growth factor 21 (FGF21) and its use in the treatment of hyperglycemic condition, insulin re...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Spanish |
Published |
12.03.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Un péptido quimérico que comprende o consiste en SEQ ID NO:2, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:69, o SEQ ID NO:70.
The invention relates to a fusion of fibroblast growth factor 19 (FGF19) and fibroblast growth factor 21 (FGF21) and its use in the treatment of hyperglycemic condition, insulin resistance, hyperinsulinemia, glucose intolerance, metabolic syndrome, obesity, undesirable body mass, nonalcoholic fatty liver disease (NAFLD) nonalcoholic steatohepatitis (NASH), atherosclerosis and related disorders. |
---|---|
AbstractList | Un péptido quimérico que comprende o consiste en SEQ ID NO:2, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:69, o SEQ ID NO:70.
The invention relates to a fusion of fibroblast growth factor 19 (FGF19) and fibroblast growth factor 21 (FGF21) and its use in the treatment of hyperglycemic condition, insulin resistance, hyperinsulinemia, glucose intolerance, metabolic syndrome, obesity, undesirable body mass, nonalcoholic fatty liver disease (NAFLD) nonalcoholic steatohepatitis (NASH), atherosclerosis and related disorders. |
Author | LING, Lei LINDHOUT, Darrin |
Author_xml | – fullname: LINDHOUT, Darrin – fullname: LING, Lei |
BookMark | eNqNijsKwkAQQLfQwt8dxl5BjGD6ELE3pRDG7AQWdneWnbHwSNYeIRczigeweu_Bm5tJ5Egzc604JBbXuTFlA3dhgQeE4alsR02YEciDZlQMjqIyWPqkKOf4nSn2lANZtCQQSPE2vLzrWJZm2qMXWv24MOtT3VTnLSVuSRJ2FEnb-rI_HspdUTZNUfzzvAHhyT_p |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | ES2748038TT3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_ES2748038TT33 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:06:31 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_ES2748038TT33 |
Notes | Application Number: ES20120807786T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200312&DB=EPODOC&CC=ES&NR=2748038T3 |
ParticipantIDs | epo_espacenet_ES2748038TT3 |
PublicationCentury | 2000 |
PublicationDate | 20200312 |
PublicationDateYYYYMMDD | 2020-03-12 |
PublicationDate_xml | – month: 03 year: 2020 text: 20200312 day: 12 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | NGM Biopharmaceuticals, Inc |
RelatedCompanies_xml | – name: NGM Biopharmaceuticals, Inc |
Score | 3.2603307 |
Snippet | Un péptido quimérico que comprende o consiste en SEQ ID NO:2, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:69, o SEQ ID NO:70.
The invention relates to a fusion of... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | Composiciones, usos y métodos para el tratamiento de trastornos y enfermedades metabólicos |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200312&DB=EPODOC&locale=&CC=ES&NR=2748038T3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1qFfWmVdH6wQrSk8Um2aS9BKFJShH6gUbpQSjdZAMFkxQ3RfxJnv0J_WPOLI160Vs2GzaZgdnZ2bz3FuBKYpZJnI6GDYomj4TRnAlstiPLkDxJDEMSG3kwdPqP_G5iTyowL7kwWif0TYsjYkRFGO-Fnq8XP5tYvsZWqhsxx1v5bS90_ca6OiaklWE2_K4bjEf-yGt4nouLquG9i8VXp2V1QmsDNnEV3Sb0V_DUJVLK4ndG6e3B1hgHy4p9qEhVgx2vPHitBtuD9f9uvFyHnjqAZ4rcnHYhSF3_mi1Vrtg7S1cfBVaWipGGN5MvjNRmZymxHHMWS2oS_jHTD0ti92H6m8VSsRQNFKtPtDdXh3DZC0Kv38TPnH67ZBo8lAaFlnUE1QxffQzMacVRLCLTtrjJ48gWQnA7MVtOjHOe5PIE6n-PU_-v8xR2yb2EvjLMM6gWr0t5jum4EBfakV_iPJOF |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB20ivWmVdH6tYL0ZLFJNjGXIDRJqdovNEoPQukmGyjYprgp4k_y7E_oH3NmadWL3rLZsMkMzM7O5r23AOcSs0zquBo2KKo8FkZ1KLB5FVuG5GlqGJLYyO2O03zkt327vwKjJRdG64S-aXFEjKgY4z3X8_X0ZxMr0NhKdSlGeCu7bkReUFlUx4S0MsxKUPfCXjfo-hXf93BR1bn3sPhya5YbWauwhitsl2T2w6c6kVKmvzNKYwvWezjYJN-GFalKUPSXB6-VYKO9-N-Nl4vQUzvwTJGb0S4EqetfsJnKFHtn4_lHjpWlYqThzeQLI7XZ4ZhYjhlLJDUJ_zjRD0ti92H6GyZSsTEaKOafaG-mduGsEUZ-s4qfOfh2ySB8WBoUWdYeFCb46n1gTi2JExGbtsVNnsS2EILbqVlzEpzzJJcHUP57nPJ_nadQbEbt1qB107k7hE1yNSGxDPMICvnrTB5jas7FiXbqF_Y1lnU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Composiciones%2C+usos+y+m%C3%A9todos+para+el+tratamiento+de+trastornos+y+enfermedades+metab%C3%B3licos&rft.inventor=LINDHOUT%2C+Darrin&rft.inventor=LING%2C+Lei&rft.date=2020-03-12&rft.externalDBID=T3&rft.externalDocID=ES2748038TT3 |